Drs. Neda Shamie and Bill Trattler discuss how genetic testing for keratoconus may help catch refractive surgery candidates who may be at risk for developing keratoconus. They also discuss the future of genetic testing in other parts of the ophthalmic practice. This is Part 2 of 2.
This activity is supported by an unrestricted educational grant from Avellino.
Upon completion of this activity, the participant should be able to:
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Evolve Medical Education designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
William B. Trattler, MD
Cornea, Cataract and Refractive Surgeon
Center for Excellence in Eye Care
Miami, Florida
Clinical Associate Professor
Herbert Wertheim College of Medicine at Florida International University
Miami, Florida
Neda Shamie, MD
Partner
Cornea, Cataract, and Refractive Surgeon
Maloney-Shamie Vision Institute
Los Angeles, California
Clinical Associate Professor
University of Southern California
Keck School of Medicine
Los Angeles, CA
William B. Trattler, MD
Cornea, Cataract and Refractive Surgeon
Center for Excellence in Eye Care
Miami, Florida
Clinical Associate Professor
Herbert Wertheim College of Medicine at Florida International University
Miami, Florida
Neda Shamie, MD
Partner
Cornea, Cataract, and Refractive Surgeon
Maloney-Shamie Vision Institute
Los Angeles, California
Clinical Associate Professor
University of Southern California
Keck School of Medicine
Los Angeles, CA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
William B. Trattler, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Bausch +Lomb, Carl Zeiss Meditec, CXLO Johnson & Johnson, and Oculus. Speaker’s Bureau: Alcon, Carl Zeiss Meditec, Johnson & Johnson, and Oculus. Stock/Shareholder: Avedro, CXLO, and Trefoil.
Neda Shamie, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Avellino, Glaukos, Staar Surgical, and Tarsus.
The Evolve and The Fundingsland Group planners have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Avellino.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
